This is the final talk that we are releasing from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology.
João Pedro de Magalhães of the University of Liverpool discussed the genetic basis of aging and the difficulties inherent in drug discovery. He also brought up the Hallmarks of Aging, the difference between humans and animals, senescent cells, and future strategies to discover therapies that allow human beings to live longer.
Write a comment: